Paul Knight
Stock Analyst at KeyBanc
(3.06)
# 2,533
Out of 4,362 analysts
260
Total ratings
41.9%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintained: Buy | $50 → $35 | $19.87 | +76.14% | 9 | May 29, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 → $5 | $1.95 | +156.41% | 3 | May 29, 2026 | |
| CYRX Cryoport | Maintained: Buy | $15 → $17 | $16.39 | +3.72% | 10 | May 20, 2026 | |
| TECH Bio-Techne | Maintained: Hold | n/a | $49.56 | - | 19 | May 7, 2026 | |
| XGN Exagen | Maintained: Buy | $15 → $10 | $4.67 | +114.36% | 11 | Mar 11, 2026 | |
| STVN Stevanato Group | Rated: Buy | $37 → $32 | $18.55 | +72.51% | 7 | Mar 5, 2026 | |
| TKNO Alpha Teknova | Maintained: Hold | n/a | $5.39 | - | 4 | Feb 27, 2026 | |
| LAB Standard BioTools | Maintained: Hold | n/a | $1.13 | - | 9 | Feb 25, 2026 | |
| RGEN Repligen | Maintained: Buy | $220 | $121.82 | +80.59% | 13 | Feb 25, 2026 | |
| LFCR Lifecore Biomedical | Maintained: Hold | n/a | $5.63 | - | 3 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $310 | $176.23 | +75.91% | 9 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $750 | $473.20 | +58.50% | 9 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 → $350 | $314.26 | +11.37% | 15 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €415.00 → €320.00 | $238.80 | +34.00% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $26.98 | +22.31% | 10 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $100.98 | +23.79% | 12 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $112.39 | +95.75% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 525.00 | $337.20 | +55.69% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $137.29 | - | 12 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $460 | $374.32 | +22.89% | 9 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $8.90 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $30 | $6.13 | n/a | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.86 | n/a | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $102.28 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 610.00 → CHF 635.00 | $488.20 | n/a | 6 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.80 | n/a | 9 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $23.68 | n/a | 9 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 | $172.78 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $177.43 | n/a | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.76 | n/a | 6 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.76 | n/a | 1 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $30 | $9.99 | n/a | 3 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.002 | n/a | 8 | Nov 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.52 | n/a | 2 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $47.45 | n/a | 7 | Nov 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $164.89 | n/a | 6 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $58.51 | n/a | 4 | Mar 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.43 | n/a | 2 | Mar 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $22.01 | n/a | 1 | Feb 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $75 → $85 | $214.95 | n/a | 2 | Jul 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $3.85 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $61 → $46 | $8.71 | n/a | 2 | Dec 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $255 | $1,170.00 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $24 | $35.78 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $18 | $0.38209999 | n/a | 1 | Aug 15, 2013 |
Castle Biosciences
May 29, 2026
Maintained: Buy
Price Target: $50 → $35
Current: $19.87
Upside: +76.14%
Rapid Micro Biosystems
May 29, 2026
Maintained: Buy
Price Target: $8 → $5
Current: $1.95
Upside: +156.41%
Cryoport
May 20, 2026
Maintained: Buy
Price Target: $15 → $17
Current: $16.39
Upside: +3.72%
Bio-Techne
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $49.56
Upside: -
Exagen
Mar 11, 2026
Maintained: Buy
Price Target: $15 → $10
Current: $4.67
Upside: +114.36%
Stevanato Group
Mar 5, 2026
Rated: Buy
Price Target: $37 → $32
Current: $18.55
Upside: +72.51%
Alpha Teknova
Feb 27, 2026
Maintained: Hold
Price Target: n/a
Current: $5.39
Upside: -
Standard BioTools
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $1.13
Upside: -
Repligen
Feb 25, 2026
Maintained: Buy
Price Target: $220
Current: $121.82
Upside: +80.59%
Lifecore Biomedical
Dec 29, 2025
Maintained: Hold
Price Target: n/a
Current: $5.63
Upside: -
Dec 18, 2025
Rated: Buy
Price Target: $310
Current: $176.23
Upside: +75.91%
Dec 8, 2025
Upgraded: Buy
Price Target: $750
Current: $473.20
Upside: +58.50%
Oct 24, 2025
Maintained: Buy
Price Target: $325 → $350
Current: $314.26
Upside: +11.37%
Oct 7, 2025
Maintained: Buy
Price Target: €415.00 → €320.00
Current: $238.80
Upside: +34.00%
Oct 3, 2025
Maintained: Buy
Price Target: $33
Current: $26.98
Upside: +22.31%
Sep 16, 2025
Maintained: Buy
Price Target: $125
Current: $100.98
Upside: +23.79%
Sep 10, 2025
Maintained: Buy
Price Target: $220
Current: $112.39
Upside: +95.75%
Sep 4, 2025
Initiated Coverage: Buy
Price Target: CHF 525.00
Current: $337.20
Upside: +55.69%
Aug 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $137.29
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $460
Current: $374.32
Upside: +22.89%
Jun 3, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $8.90
Upside: n/a
Apr 9, 2025
Downgraded: Hold
Price Target: $7 → $30
Current: $6.13
Upside: n/a
Mar 31, 2025
Downgraded: Hold
Price Target: n/a
Current: $25.86
Upside: n/a
Feb 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $102.28
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: CHF 610.00 → CHF 635.00
Current: $488.20
Upside: n/a
May 9, 2024
Rated: Hold
Price Target: n/a
Current: $4.80
Upside: n/a
Nov 14, 2023
Rated: Hold
Price Target: n/a
Current: $23.68
Upside: n/a
May 5, 2022
Maintained: Buy
Price Target: $300
Current: $172.78
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $250
Current: $177.43
Upside: n/a
Mar 14, 2022
Downgraded: Hold
Price Target: n/a
Current: $5.76
Upside: n/a
Apr 15, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $1.76
Upside: n/a
Feb 27, 2020
Maintained: Hold
Price Target: $20 → $30
Current: $9.99
Upside: n/a
Nov 26, 2019
Downgraded: Hold
Price Target: $6 → $2
Current: $0.002
Upside: n/a
Jul 24, 2019
Downgraded: Hold
Price Target: n/a
Current: $5.52
Upside: n/a
Nov 29, 2018
Downgraded: Hold
Price Target: n/a
Current: $47.45
Upside: n/a
Oct 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $164.89
Upside: n/a
Mar 27, 2017
Downgraded: Hold
Price Target: n/a
Current: $58.51
Upside: n/a
Mar 11, 2016
Downgraded: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
Feb 10, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $22.01
Upside: n/a
Jul 24, 2014
Downgraded: Hold
Price Target: $75 → $85
Current: $214.95
Upside: n/a
May 5, 2014
Upgraded: Buy
Price Target: n/a
Current: $3.85
Upside: n/a
Dec 19, 2013
Rated: Hold
Price Target: $61 → $46
Current: $8.71
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $255
Current: $1,170.00
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $24
Current: $35.78
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $18
Current: $0.38209999
Upside: n/a